Dexcom G7 vs FreeStyle Libre 3: full comparison
Dexcom G7 vs FreeStyle Libre 3: a full spec-by-spec comparison of accuracy, warmup time, wear duration, alarms, and cost to help you choose the right CGM.
| Dexcom G7 Wear Duration | 10 days + 12-hour grace period |
| Libre 3 Wear Duration | 14 days (US) / 15 days (EU) |
| Dexcom G7 Warmup | ~30 minutes |
| Libre 3 Warmup | ~60 minutes |
| Dexcom G7 MARD | ~8.2% |
| Libre 3 MARD | ~7.8% |
| Dexcom G7 Reading Interval | Every 5 minutes |
| Libre 3 Reading Interval | Every 1 minute |
| Dexcom G7 Cost (no insurance) | ~$350–$400/month |
| Libre 3 Cost (no insurance) | ~$75–$130/month |
Key Takeaways
- Dexcom G7 has a 30-minute warmup vs FreeStyle Libre 3's 60-minute warmup
- Both sensors last 10–15 days, but G7 offers a 12-hour grace period after expiry
- Dexcom G7 delivers real-time alerts; Libre 3 added optional real-time glucose alarms in 2023
- G7 MARD: ~8.2%; Libre 3 MARD: ~7.8% — both clinically excellent
- Libre 3 is typically cheaper out-of-pocket; G7 has broader Medicare/insurance coverage in the US
- Neither sensor requires fingerstick calibration under normal conditions
Overview
The Dexcom G7 and Abbott FreeStyle Libre 3 are the two leading continuous glucose monitors (CGMs) available in 2024. Both are factory-calibrated, small-form wearables aimed at people with Type 1 and Type 2 diabetes. Choosing between them depends on your clinical needs, lifestyle, insurance coverage, and how you use glucose data day-to-day.
Full Specifications Comparison
| Feature | Dexcom G7 | FreeStyle Libre 3 |
|---|---|---|
| Sensor Wear Duration | 10 days + 12-hour grace period | 14 days (US) / 15 days (EU) |
| Warmup Time | ~30 minutes | ~60 minutes |
| MARD (Accuracy) | ~8.2% | ~7.8% |
| Reading Interval | Every 5 minutes | Every 1 minute |
| Transmission Range | ~6 metres (Bluetooth) | ~3 metres (Bluetooth) |
| Calibration Required | No (optional) | No |
| Real-Time Alerts | Yes — urgent low, high, rapid rise/fall | Yes (from Libre 3+ / app update 2023) |
| Predictive Alerts | Yes (20-min urgent low soon) | Limited |
| Receiver Required | Optional (sold separately) | Smartphone only (no dedicated receiver) |
| Water Resistance | IP28 — up to 2.4 m for 24 hrs | IP27 — up to 1 m for 30 mins |
| Sensor Size | Smallest Dexcom to date; all-in-one (no transmitter) | Ultra-thin, ~70% smaller than Libre 2 |
| Compatible Devices | iOS, Android, dedicated receiver | iOS, Android (no receiver) |
| Insulin Pump Integration | Tandem t:slim X2, Omnipod 5 | Limited (expanding) |
| Share / Follow Feature | Yes — up to 10 followers | Yes — up to 20 followers (LibreLinkUp) |
| Average US Cost (per month) | ~$350–$400 without insurance | ~$75–$130 without insurance |
Accuracy Deep Dive
Both sensors are FDA-approved and perform well across clinical studies. The Libre 3 edges out a slightly lower MARD (Mean Absolute Relative Difference) of ~7.8% versus the G7's ~8.2%, but in everyday use this difference is rarely clinically meaningful. Accuracy can dip during rapid glucose changes (lag time) in both devices — typically 5–10 minutes behind blood glucose. Neither should be used for insulin dosing decisions during symptoms without a fingerstick confirmaiton if readings seem inconsistent.
Alarms and Alerts
This is the biggest practical difference. Dexcom G7 offers a comprehensive alarm suite: Urgent Low (55 mg/dL), customisable High and Low thresholds, Rate of Change alerts, and an "Urgent Low Soon" predictive alert that fires ~20 minutes before projected hypoglycaemia. This makes the G7 the clear choice for people at high hypoglycaemia risk or those using closed-loop systems.
The FreeStyle Libre 3 (and Libre 3+) now offers real-time alarms including Low Glucose, High Glucose, and Signal Loss alerts. However, its predictive alerting capability remains less sophisticated than Dexcom's.
Ease of Use and Wearability
The Libre 3 wins on simplicity. It is one piece (no separate transmitter), extremely thin, and largely discreet under clothing. The G7 is also an all-in-one redesign from the G6, significantly smaller, but slightly bulkier than Libre 3. Both use a one-click automatic inserter. The Libre 3 sits flush to the skin on the back of the upper arm; the G7 can be worn on the abdomen or back of the upper arm.
Integration with Insulin Pumps and Apps
Dexcom G7 is the better choice if you use an automated insulin delivery (AID) system. It integrates natively with the Tandem t:slim X2 Control-IQ and Omnipod 5 systems. Libre 3 integration with AID systems is expanding but currently more limited. For data-hungry users, Dexcom also integrates with Garmin, Apple Watch, and more third-party platforms.
Cost and Insurance
FreeStyle Libre 3 is substantially cheaper out-of-pocket — approximately $75–$130/month versus $350–$400 for Dexcom G7. Abbott also offers more aggressive savings programmes. However, Dexcom G7 has broad Medicare Part B coverage and is often preferred by US commercial insurers for Type 1 patients. Always verify your specific plan. MDS Diabetes stocks both sensor lines — check the CGM sensors category for current pricing and availability.
Who Should Choose Which?
Choose Dexcom G7 if you:
- Use or plan to use an AID insulin pump (Tandem, Omnipod 5)
- Need robust, customisable hypoglycaemia alerts
- Want the most comprehensive third-party app integrations
- Have Medicare or insurance that covers it fully
Choose FreeStyle Libre 3 if you:
- Are cost-conscious and paying out-of-pocket
- Prefer a simpler, lower-profile sensor
- Have Type 2 diabetes and primarily track trends (not alarms)
- Want the longest single wear duration (14–15 days)